(Q33811345)

29 July 2017

1 reference

title

Immune dysfunction in trauma (English)

1 reference

29 July 2017

Napolitano LM

1

1 reference

29 July 2017

Faist E

series ordinal

2

1 reference

29 July 2017

Wichmann MW

series ordinal

3

1 reference

29 July 2017

Coimbra R

series ordinal

4

1 reference

29 July 2017

publication date

1 December 1999

1 reference

Surgical Clinics of North America

29 July 2017

published in

1 reference

29 July 2017

volume

79

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

1385-1416

1 reference

Hemorrhage in mice induces alterations in immunoglobulin-secreting B cells

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Testosterone receptor blockade after hemorrhage in males. Restoration of the depressed immune functions and improved survival following subsequent sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Hypertonic saline resuscitation reduces neutrophil margination by suppressing neutrophil L selectin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Mechanism of enhanced susceptibility to sepsis following hemorrhage. Interleukin-10 suppression of T-cell response is mediated by eicosanoid-induced interleukin-4 release.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Enhanced Susceptibility to Sepsis After Simple Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Insights into the mechanism by which interferon-gamma improves macrophage function following hemorrhage and resuscitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effects of pentoxifylline on hemodynamics and oxygenation in septic and nonseptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Epidemiology of trauma deaths

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

The horror autotoxicus and multiple-organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

The pathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Femur fracture induces site-specific changes in T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Cellular mechanisms involved in morphine-mediated suppression of CTL activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Redistribution of blood flow after thermal injury and hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Triazolodiazepines are potent antagonists of platelet activating factor (PAF) in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Pentoxifylline in the Treatment of Experimental Peritonitis in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Use of ATP following shock and ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Inhibition of apoptosis in polymorphonuclear neutrophils from burn patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Soluble cytokine receptors and receptor antagonists are sequentially released after trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effects of Granulocyte-Macrophage Colony-Stimulating Factor in Burn Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis--a randomized, clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Hypertonic saline resuscitation restores hemorrhage-induced immunosuppression by decreasing prostaglandin E2 and interleukin-4 production

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Hypertonic saline attenuates the hormonal response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Animal models of sepsis and shock: a review and lessons learned.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Bactericidal/permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: results of a multicenter phase II clinical trial. rBPI21 Acute Hemorrhagic Trauma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

1 reference

7 January 2021

Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

CDP571, a humanized antibody to human tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Interferon-gamma therapy for infectious complications of injury: a called third strike?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Chloroquine attenuates hemorrhagic shock-induced immunosuppression and decreases susceptibility to sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Modulation of Macrophage Membrane Phospholipids by n-3 Polyunsaturated Fatty Acids Increases Interleukin 1 Release and Prevents Suppression of Cellular Immunity Following Hemorrhagic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

The immune-enhancing effect of perioperative thymopentin administration in elderly patients undergoing major surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Immunomodulatory therapy with thymopentin and indomethacin. Successful restoration of interleukin-2 synthesis in patients undergoing major surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Prostaglandin E2 (PGE2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Alteration of monocyte function following major injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Pentoxifylline but not saralasin restores hepatic blood flow after resuscitation from hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Septic shock: pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Multiple-organ failure. Generalized autodestructive inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Biologic control of injury and inflammation: much more than too little or too late

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effects of accidental trauma on cytokine and endotoxin production

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

3% NaCl and 7.5% NaCl/dextran 70 in the resuscitation of severely injured patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Bacterial action in development of irreversibility to transfusion in hemorrhagic shock in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Intestinal fatty acid binding protein is available for diagnosis of intestinal ischaemia: immunochemical analysis of two patients with ischaemic intestinal diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Intestinal fatty acid-binding protein as a sensitive marker of intestinal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Trauma and thermal injury: comparison of hemostatic and cytokine changes in the acute phase of injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Early prediction of septic complications after cardiac surgery by APACHE II score

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Loss of upper respiratory tract immunity with parenteral feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effects of parenteral and enteral nutrition on gut-associated lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Organ failure, infection, and the systemic inflammatory response syndrome are associated with elevated levels of urinary intestinal fatty acid binding protein: study of 100 consecutive patients in a surgical intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

ARDS, neutrophils, and pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Alterations of cell-mediated immune response following cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Neutrophil apoptosis in the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Bacteremia at Boston City Hospital: Occurrence and Mortality during 12 Selected Years (1935-1972), with Special Reference to Hospital-Acquired Cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Impaired antibody production in blunt trauma. Possible role for T cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Mechanism of diltiazem's immunomodulatory effects after hemorrhage and resuscitation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effects of an immune-enhancing diet in critically injured patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

The role of pentoxifylline in endotoxin-induced alterations of red cell deformability and whole blood viscosity in the neonate.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Clinical benefits of an immune-enhancing diet for early postinjury enteral feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Nitric oxide inhibition normalizes splenocyte interleukin-10 synthesis in murine thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

A membrane TNF-alpha/TNFR ratio correlates to MODS score and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

A randomized prospective clinical trial to determine the efficacy of interferon-γ in severely injured patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Immunoregulatory role of neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Severe head injury: effect upon cellular immune function.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

On the absorption of bacterial endotoxin from the gastro-intestinal tract of the normal and shocked animal

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Lactated Ringer's solution resuscitation causes neutrophil activation after hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Anti-endotoxin therapy in primate bacteremia with HA-1A and BPI.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Apoptosis in resolution of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Persistent Arteriolar Constriction in Microcirculation of the Terminal Ileum following Moderate Hemorrhagic Hypovolemia and Volume Restoration

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Regional flow during experimental hemorrhage and crystalloid resuscitation: persistence of low flow to the splanchnic organs

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Mediators of injury and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Gender differences in human sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Antithrombotic potential of pentoxifylline. A hemorheologically active drug

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Transmural migration of intestinal bacteria; a study based on the use of radioactive Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Hemorrhagic shock in the dog. II. Studies on central hemodynamics and regional blood flow.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Role of Interferon- in Experimental Gram-Negative Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Regional differences in lymphocyte function following resuscitated hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Detection, tissue distribution and (sub)cellular localization of fatty acid-binding protein types

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Mechanism of the beneficial effects of ATP-MgCl2 following trauma-hemorrhage and resuscitation: Downregulation of inflammatory cytokine (TNF, IL-6) release

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Interferon-gamma in the prevention of severe burn-related infections: a European phase III multicenter trial. The Severe Burns Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

High-dose antithrombin III treatment of severely injured patients: results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Influence of arginine, omega-3 fatty acids and nucleotide-supplemented enteral support on systemic inflammatory response syndrome and multiple organ failure in patients after severe trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

1 reference

7 January 2021

Melatonin Administration Following Hemorrhagic Shock Decreases Mortality from Subsequent Septic Challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Mechanism of immunosuppression in males following trauma-hemorrhage. Critical role of testosterone.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Melatonin Administration Attenuates Depressed Immune Functions after Trauma-Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Immune function is more compromised after closed bone fracture and hemorrhagic shock than hemorrhage alone

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Sepsis and septic shock--a review of laboratory models and a proposal

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Mechanism of Intestinal Mucosal Immune Dysfunction Following Trauma–Hemorrhage: Increased Apoptosis Associated with Elevated Fas Expression in Peyer's Patches

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

The sirens' songs of confirmatory sepsis trials: selection bias and sampling error.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Circulating postinjury neutrophils are primed for the release of proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

PAF-Antagonist Administration after Hemorrhage-Resuscitation Prevents Splenocyte Immunodepression

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

A Novel Nonanticoagulant Heparin Improves Splenocyte and Peritoneal Macrophage Immune Function after Trauma-Hemorrhage and Resuscitation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

1 reference

7 January 2021

Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Prolactin: A Novel and Safe Immunomodulating Hormone for the Treatment of Immunodepression Following Severe Hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Mechanism of immunologic suppression in burn injury

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Microcirculatory Flow Changes After Initial Resuscitation of Hemorrhagic Shock with 7.5% Hypertonic Saline/6% Dextran 70

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

The effects of injury on the adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Depression of Cellular Immunity after Multiple Trauma in the Absence of Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

Pentoxifylline in resuscitation of experimental hemorrhagic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6109%2805%2970084-0

7 January 2021

10.1016/S0039-6109(05)70084-0

Identifiers

DOI

1 reference

29 July 2017

1 reference